Elevated Serum IL-17A in Kawasaki Disease Patients Predicts Responsiveness to Intravenous Immunoglobulin Therapy
Serum IL-17A levels were remarkably elevated in IVIG-nonresponsive KD patients both before and after intervention. A serum IL-17A level (≥39.96 pg/mL) demonstrated good predictive profile for IVIG-nonresponsive KD, and combining IL-17A with CRP, WBC, and ALT improved diagnostic performance.
Authors
- Fang-Qi Hu
- Yan Lü (ORCID: https://orcid.org/0000-0002-5893-6114)
Institutions
- Anqing City Hospital (CN)
Publication Details
- Journal
- International Archives of Allergy and Immunology
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1159/000540697
- Citations
- 2
- Primary Topic
- Kawasaki Disease and Coronary Complications
- Type
- article
- Field-Weighted Citation Impact
- 1.15